A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease

Neuroscience Letters

Volumn 263, Issue 2-3, 1999, Pages 129-132

  Kamboh, M Ilyas ^a,d   Aston, Christopher E ^a   Perez Tur, Jordi ^b   Kokmen, Emre ^c   Ferrell, Robert E ^a   Hardy, John ^b   DeKosky, Steven T ^a,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC ROCHESTER   (United States)

^d Neurol Alzheimer's Dis Res C   (United States)

Author keywords

APOE*4 Pittsburgh; Late onset Alzheimer's disease

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; DNA SEQUENCE; ENVIRONMENTAL FACTOR; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE STRUCTURE; GENETIC RISK; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; EXONS; FEMALE; HUMANS; LEUCINE; MALE; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROLINE; REFERENCE VALUES; REGISTRIES; RISK FACTORS; UNITED STATES;

EID: 0033605611     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00129-9     Document Type: Article

References (7)

1. Corder E., Saunders A., Strittmatter W., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
2. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., Van Duijin C.M. for the Alzheimer Disease Meta Analysis Consortium, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. J. Am. Med. Assoc. 278:1997;1349-1356.
3. Hardy J. Molecular genetics of Alzheimer's disease (review). Acta Neurol. Scand. (Suppl.). 165:1996;13-17.
4. Kamboh M.I., Aston C.E., Hamman R.F. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis. 112:1995;145-159.
5. Kamboh M.I., Sanghera D.K., Aston C.E., Bunker C.H., Hamman R.F., Ferrell R.E., DeKosky S.T. Gender-specific nonrandom association between the α1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease. Genet. Epidemiol. 14:1997;169-180.
6. Strittmatter D., Saunders A., Schmechel D., Pericak-Vance M., Enghild I., Salvesen G., Roses A. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
7. Tang M.X., Stern Y., Marder K., Bell K., Gurland B., Lantigua R., Andrews H., Feng L., Tycko B., Mayeux R. The APOE- 4 allele and the risk of Alzheimer's disease among African-Americans. Whites and Hispanics. J. Am. Med. Assoc. 279:1998;751-755.